Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,349 | 55,465 | 887 | 0 | 0 |
| Other current assets | 70 | 44 | 0 | 0 | 0 |
| TOTAL | $51,088 | $56,317 | $890 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 122 | 4 | 4 | N/A | N/A |
| Other Non-Current Assets | 0 | 0 | 461 | 0 | 0 |
| TOTAL | $122 | $4 | $465 | $N/A | $N/A |
| Total Assets | $51,210 | $56,321 | $1,355 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 889 | 3,948 | 951 | 0 | 0 |
| Accrued Expenses | 500 | 267 | 1,015 | 0 | 0 |
| TOTAL | $1,389 | $4,215 | $2,337 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,389 | $4,215 | $2,337 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 978 | 978 | N/A | N/A | N/A |
| Common Shares | 16 | 16 | 10 | 0 | 0 |
| Retained earnings | -11,758 | -8,732 | -4,450 | 0 | 0 |
| TOTAL | $49,821 | $52,106 | $-982 | $0 | $0 |
| Total Liabilities And Equity | $51,210 | $56,321 | $1,355 | $0 | $0 |